Portugal (PT)

Clinical and histopathological characterization of penile carcinomas with focus on HPV-status and histological subtype (2022) Mink J, Khalmurzaev O, Hoelters S, Pryalukhin A, Heinzelbecker J, Lohse S, Bende K, et al. Conference contribution Global Matrix 4.0 Physical Activity Report Card Grades for Children and Adolescents: Results and Analyses From 57 Countries (2022) Aubert S, Barnes JD, Demchenko I, Hawthorne M, Abdeta C, Nader PA, Sala JCA, et al. Journal article Neoadjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy, followed by adjuvant pembrolizumab versus placebo for early-stage TNBC: Event-free survival sensitivity and subgroup analyses from KEYNOTE-522 (2022) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kuemmel S, Bergh J, et al. Conference contribution Investigation of Different Methods of Intraoperative Graft Perfusion Assessment during Kidney Transplantation for the Prediction of Delayed Graft Function: A Prospective Pilot Trial (2022) Gerken AL, Keese M, Weiss C, Krücken HS, Pecher KA, Ministro A, Rahbari NN, et al. Journal article Clinical autonomic nervous system laboratories in Europe A joint survey of the European Academy of Neurology and the European Federation of Autonomic Societies (2022) Habek M, Leys F, Skoric MK, Carneiro DR, Calandra-Buonaura G, Camaradou J, Chiaro G, et al. Journal article A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy (2022) Buettner FA, Winter S, Stuehler V, Rausch S, Hennenlotter J, Füssel S, Zastrow S, et al. Journal article Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database (2022) Iudici M, Mongin D, Siegert E, Carreira PE, Distler J, Henes J, Zanatta E, et al. Journal article Atomically Dispersed Pentacoordinated-Zirconium Catalyst with Axial Oxygen Ligand for Oxygen Reduction Reaction (2022) Wang X, An Y, Liu L, Fang L, Liu Y, Zhang J, Qi H, et al. Journal article Persistent inflammation in systemic sclerosis is strongly associated with mortality: a EUSTAR database analysis (2022) Guler SA, Sarbu A, Stadler O, Allanore Y, Bernardino , Distler J, Gabrielli A, et al. Conference contribution HRQoL with neoadjuvant pembrolizumab plus chemotherapy vs placebo plus chemotherapy, followed by adjuvant pembrolizumab vs placebo for early-stage TNBC: Results from KEYNOTE-522 (2022) Dent RA, Cortes J, Pusztai L, Mcarthur HL, Kuemmel S, Bergh J, Denkert C, et al. Conference contribution